Jan 12, 2022 / 08:45PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
All right, good afternoon. Welcome, everybody, to our panel on synthetic biology. We've got a great group of speakers with us today. Quick round of introductions from JPMorgan. It's myself and Rachel from our team. We've got (inaudible) from [Capitol Street]. And then for our panelists, we've got Max Bronstein from the White House Office of Science and Technology. We've got Jason Kelly from Ginkgo; Sri Kosaraju from Inscripta; and Gregory Yep from International Flavors & Fragrances.
I thought to kick it off, maybe each of you could just give us a quick overview of your respective companies and positions and how it relates to synthetic biology. Max, we'll start with you coming out of the White House Office of Science and Technology. Talk a little bit about your role in the synthetic biology universe.
Max Bronstein -
Well, thanks very much for having me Tycho. And I'm just excited to be here at JPMorgan. I'm the Assistant Director for Health Innovation at OSTP. And I've been doing
Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers